These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 23356028)

  • 21. Drug resistance in leprosy: lessons from past and future perspective.
    Gupta UD; Katoch VM
    Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
    Guerrero MI; Colorado CL; Torres JF; León CI
    Biomedica; 2014 Apr; 34 Suppl 1():137-47. PubMed ID: 24968045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Present situation of leprosy in Japan, 2006-2010: analysis of drug resistance in new registered and relapsed cases by molecular biological methods.
    Mori S; Yotsu RR; Suzuki K; Makino M; Ishii N
    J Dermatol Sci; 2012 Sep; 67(3):192-4. PubMed ID: 22739027
    [No Abstract]   [Full Text] [Related]  

  • 24. qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients.
    Araujo S; Goulart LR; Truman RW; Goulart IMB; Vissa V; Li W; Matsuoka M; Suffys P; Fontes AB; Rosa PS; Scollard DM; Williams DL
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005506. PubMed ID: 28570560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress in the chemotherapy of leprosy.
    Grosset JH
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):268-77. PubMed ID: 8046266
    [No Abstract]   [Full Text] [Related]  

  • 26. [Novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries].
    Matsuoka M; Suzuki Y; Makino M
    Nihon Hansenbyo Gakkai Zasshi; 2010 Sep; 79(3):257-61. PubMed ID: 20857655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug resistance in patients with leprosy in the United States.
    Williams DL; Lewis C; Sandoval FG; Robbins N; Keas S; Gillis TP; Scollard DM
    Clin Infect Dis; 2014 Jan; 58(1):72-3. PubMed ID: 24065328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of polymerase chain reaction to assess efficacy of leprosy chemotherapy.
    Jamil S; Keer JT; Lucas SB; Dockrell HM; Chiang TJ; Hussain R; Stoker NG
    Lancet; 1993 Jul; 342(8866):264-8. PubMed ID: 8101301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does dapsone resistance really matter in the MDT era?
    Ji B
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending The Leprosy Mission (TLM) Hospitals in India.
    Lavania M; Jadhav RS; Chaitanya VS; Turankar R; Selvasekhar A; Das L; Darlong F; Hambroom UK; Kumar S; Sengupta U
    Lepr Rev; 2014 Sep; 85(3):177-85. PubMed ID: 25509718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening of drug resistant strains of Mycobacterium leprae in lepromatous leprosy patients under multidrug treatment.
    Sreevatsa ; Girdhar BK; Desikan KV
    Indian J Med Res; 1988 Feb; 87():139-43. PubMed ID: 3294170
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical utility of LSR/A15 gene for Mycobacterium leprae detection in leprosy tissues using the polymerase chain reaction.
    Misra N; Ramesh V; Misra RS; Narayan NP; Colston MJ; Nath I
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):35-41. PubMed ID: 7730717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for
    Mahajan NP; Lavania M; Singh I; Nashi S; Preethish-Kumar V; Vengalil S; Polavarapu K; Pradeep-Chandra-Reddy C; Keerthipriya M; Mahadevan A; Yasha TC; Nandeesh BN; Gnanakumar K; Parry GJ; Sengupta U; Nalini A
    Am J Trop Med Hyg; 2020 Mar; 102(3):547-552. PubMed ID: 31933458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dormancy, drug resistance or dependency; some thoughts to ponder.
    Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116
    [No Abstract]   [Full Text] [Related]  

  • 35. History and characteristics of isolates maintained at the leprosy research center.
    Matsuoka M
    Nihon Hansenbyo Gakkai Zasshi; 2010 Sep; 79(3):247-56. PubMed ID: 20857654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance.
    Waters MF; Pearson JM; Rees RJ
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):152-3. PubMed ID: 776850
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug resistance of multibacillary leprosy patients in Japan--results of molecular genetic analyses].
    Ozaki M
    Nihon Hansenbyo Gakkai Zasshi; 2008 Sep; 77(3):187-96. PubMed ID: 18800639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple mutations in the rpoB gene of Mycobacterium leprae strains from leprosy patients in Thailand.
    Ramasoota P; Wongwit W; Sampunachot P; Unnarat K; Ngamying M; Svenson SB
    Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):493-7. PubMed ID: 11289008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A colorimetric PCR method for the detection of M. leprae in skin biopsies from leprosy patients.
    Jamil S; Wilson SM; Hacket M; Hussain R; Stoker NG
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):512-20. PubMed ID: 7868947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs.
    Almeida JG
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.